Abuse drugs and derivatives

(±)-PMMA-13C6 (ring 13C6) hydrochloride

(±)-PMMA-13C6 (ring 13C6) hydrochloride

(±)-t-11-Nor-9-carboxy-d9-THC-d3 (pentyl-5,5,5-d3)

(±)-t-11-Nor-9-carboxy-d9-THC-d3(pentyl-5,5,5-d3)

(±)-trans-11-Nor-9-carboxy-Δ9-THC, 100μg/ml in MeOH, 1ml

(±)-Zopiclone-13C4 (piperazinyl-13C4)

(±)-Zopiclone-13C4 (piperazinyl-13C4)

(±)-Zopiclone-d8 (piperazinyl-d8)

(±)-Zopiclone-d8 (piperazinyl-d8)

(1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-)-napht

(1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-)-napht

(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone

(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone

(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone

(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone

(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone-d9

(1-Naphthalenyl)-(1-(5-fluoropentyl)-1H-indol-3-yl

(1-Naphthalenyl)-(1-(5-fluoropentyl)-1H-indol-3-yl

(1R,2R)-(-)-Pseudoephedrine

(1R,2R)-(-)-Pseudoephedrine-d3 HCl (N-methyl-d3)

(1R,2R)-(-)-Pseudoephedrine, 1g

(1R,2S)-(-)-Ephedrine

(1R,2S)-(-)-Ephedrine hydrochloride

(1R,2S)-(-)-Ephedrine hydrochloride